학술논문

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain
Document Type
Article
Source
In: Cancers. (Cancers, June 2023, 15(11))
Subject
Language
English
ISSN
20726694